Related Experiment Videos
Does ramosetron reduce postoperative emesis and pain after TKA?
In Jun Koh1, Chong Bum Chang, Young-Tae Jeon
1Joint Reconstruction Center, Seoul National University, Bundang Hospital, Seongnamsi, Korea.
Clinical Orthopaedics and Related Research
|December 14, 2011
Summary
Ramosetron prophylaxis did not significantly reduce postoperative emetic events or improve pain control after total knee arthroplasty (TKA). Further research is needed for better nausea management in TKA patients.
Area of Science:
- Orthopedic Surgery
- Anesthesiology
- Pharmacology
Background:
- Multimodal pain management after total knee arthroplasty (TKA) often involves various anesthetic and analgesic drugs.
- While effective for pain, these protocols present challenges in controlling associated emetic events (nausea and vomiting).
Purpose of the Study:
- To evaluate the efficacy of ramosetron prophylaxis in reducing postoperative emetic events following TKA.
- To assess the impact of ramosetron on pain levels and opioid consumption within a multimodal pain management strategy.
Main Methods:
- A randomized controlled trial involving 119 patients undergoing TKA.
- Patients received either ramosetron prophylaxis or no prophylaxis, alongside standardized multimodal analgesia (regional anesthesia, nerve blocks, periarticular injections, PCA).
- Emetic events, nausea severity (VAS), rescue antiemetic use, pain, and opioid consumption were monitored over 48 hours postoperatively.
Main Results:
- Ramosetron showed a trend towards reduced nausea and fewer rescue antiemetic needs between 6-24 hours postoperatively.
- However, overall incidences of emetic events, antiemetic requirements, and complete response were similar between the ramosetron and control groups.
- No significant differences were observed in pain levels or opioid consumption between the groups.
Conclusions:
- Ramosetron prophylaxis provided limited benefit, only reducing emetic events during a specific postoperative window (6-24 hours).
- The drug did not influence overall pain management or opioid use in this TKA patient cohort.
- More effective strategies are required to comprehensively manage postoperative emetic events after TKA.
Related Concept Videos
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
01:26Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...